Dr. Christian Pagnoux, MD, MS, MPH
Claim this profileMount Sinai Hospital
Studies Vasculitis
Studies Granulomatosis with Polyangiitis
5 reported clinical trials
6 drugs studied
Affiliated Hospitals
Clinical Trials Christian Pagnoux, MD, MS, MPH is currently running
Abatacept
for Giant Cell Arteritis
This randomized, double-blind, placebo-controlled trial will seek to determine the efficacy of abatacept in GCA. To examine this objective, 62 eligible patients who have newly diagnosed or relapsing GCA within 8 weeks prior to screening will be randomized at a 1:1 ratio to receive subcutaneous abatacept 125mg/week or placebo. Patients who achieve remission will remain on their blinded assignment for 12 months at which time abatacept/placebo will be stopped. Patients who do not achieve remission by Month 3, who experience a relapse within the first 12 months will have the option of receiving open-label abatacept for a maximum of 12 months.
Recruiting1 award Phase 36 criteria
DNA Study
for Vasculitis
The purpose of this study is to identify genes that increase the risk of developing vasculitis, a group of severe diseases that feature inflammation of blood vessels. Results of these studies will provide vasculitis researchers with insight into the causes of these diseases and generate new ideas for diagnostic tests and therapies, and will be of great interest to the larger communities of researchers investigating vasculitis and other autoimmune, inflammatory, and vascular diseases.
Recruiting1 award N/A10 criteria
More about Christian Pagnoux, MD, MS, MPH
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Christian Pagnoux, MD, MS, MPH has experience with
- Abatacept
- Placebo
- Prednisone
- One-Time DNA Study
- Depemokimab
- Mepolizumab
Breakdown of trials Christian Pagnoux, MD, MS, MPH has run
Vasculitis
Granulomatosis with Polyangiitis
Wegener's Granulomatosis
Giant Cell Arteritis
Eosinophilic Granulomatosis with Polyangiitis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christian Pagnoux, MD, MS, MPH specialize in?
Christian Pagnoux, MD, MS, MPH focuses on Vasculitis and Granulomatosis with Polyangiitis. In particular, much of their work with Vasculitis has involved treating patients, or patients who are undergoing treatment.
Is Christian Pagnoux, MD, MS, MPH currently recruiting for clinical trials?
Yes, Christian Pagnoux, MD, MS, MPH is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Christian Pagnoux, MD, MS, MPH has studied deeply?
Yes, Christian Pagnoux, MD, MS, MPH has studied treatments such as Abatacept, Placebo, Prednisone.
What is the best way to schedule an appointment with Christian Pagnoux, MD, MS, MPH?
Apply for one of the trials that Christian Pagnoux, MD, MS, MPH is conducting.
What is the office address of Christian Pagnoux, MD, MS, MPH?
The office of Christian Pagnoux, MD, MS, MPH is located at: Mount Sinai Hospital, Toronto, Ontario M5T 3L9 Canada. This is the address for their practice at the Mount Sinai Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.